GUFIC BIOSCIENCES
Quarterly Results Analysis [Dec2023]
GUFIC BIOSCIENCES Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 Audited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹202 Cr | ₹215 Cr | ₹195 Cr | ₹173 Cr | ₹177 Cr | ₹175 Cr | ₹165 Cr | ₹162 Cr |
Expenses | ₹165 Cr | ₹176 Cr | ₹160 Cr | ₹141 Cr | ₹144 Cr | ₹142 Cr | ₹132 Cr | ₹130 Cr |
Operating Income | ₹36 Cr | ₹39 Cr | ₹35 Cr | ₹32 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr |
Profit Before Tax | ₹30 Cr | ₹31 Cr | ₹28 Cr | ₹24 Cr | ₹27 Cr | ₹27 Cr | ₹28 Cr | ₹26 Cr |
Profit After Tax | ₹22 Cr | ₹23 Cr | ₹21 Cr | ₹18 Cr | ₹20 Cr | ₹20 Cr | ₹21 Cr | ₹20 Cr |
EPS | ₹2.22 | ₹2.39 | ₹2.13 | ₹1.87 | ₹2.10 | ₹2.09 | ₹2.17 | ₹2.09 |
Industry Peers & Returns | 1W | 1M | 1Y |
GUFIC BIOSCIENCES | 0.4% | -7.8% | 52.5% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
GUFIC BIOSCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -6.09 % |
Y-o-Y | 13.70 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹202 Cr | -6.09 | |
Sep2023 | ₹215 Cr | 10.18 | |
Jun2023 | ₹195 Cr | 12.70 | |
Mar2023 | ₹173 Cr | -2.50 | |
Dec2022 | ₹177 Cr | 1.51 | |
Sep2022 | ₹175 Cr | 5.78 | |
Jun2022 | ₹165 Cr | 1.90 | |
Mar2022 | ₹162 Cr | - |
GUFIC BIOSCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -7.40 % |
Y-o-Y | 9.18 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹36 Cr | -7.40 | |
Sep2023 | ₹39 Cr | 10.97 | |
Jun2023 | ₹35 Cr | 10.35 | |
Mar2023 | ₹32 Cr | -3.72 | |
Dec2022 | ₹33 Cr | 2.39 | |
Sep2022 | ₹33 Cr | -1.71 | |
Jun2022 | ₹33 Cr | 1.57 | |
Mar2022 | ₹33 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -1.36 % |
Y-o-Y | -3.93 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 18.07% | -1.36 | |
Sep2023 | 18.32% | 0.71 | |
Jun2023 | 18.19% | -2.10 | |
Mar2023 | 18.58% | -1.22 | |
Dec2022 | 18.81% | 0.86 | |
Sep2022 | 18.65% | -7.08 | |
Jun2022 | 20.07% | -0.35 | |
Mar2022 | 20.14% | - |
GUFIC BIOSCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -4.11 % |
Y-o-Y | 9.45 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹22 Cr | -4.11 | |
Sep2023 | ₹23 Cr | 12.54 | |
Jun2023 | ₹21 Cr | 13.91 | |
Mar2023 | ₹18 Cr | -10.97 | |
Dec2022 | ₹20 Cr | 0.61 | |
Sep2022 | ₹20 Cr | -3.99 | |
Jun2022 | ₹21 Cr | 3.88 | |
Mar2022 | ₹20 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 2.13 % |
Y-o-Y | -3.75 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 11.03 % | 2.13 | |
Sep2023 | 10.8 % | 2.08 | |
Jun2023 | 10.58 % | 1.15 | |
Mar2023 | 10.46 % | -8.73 | |
Dec2022 | 11.46 % | -0.87 | |
Sep2022 | 11.56 % | -9.26 | |
Jun2022 | 12.74 % | 2.00 | |
Mar2022 | 12.49 % | - |
GUFIC BIOSCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -7.11 % |
Y-o-Y | 5.71 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹2.22 | -7.11 | |
Sep2023 | ₹2.39 | 12.21 | |
Jun2023 | ₹2.13 | 13.90 | |
Mar2023 | ₹1.87 | -10.95 | |
Dec2022 | ₹2.1 | 0.48 | |
Sep2022 | ₹2.09 | -3.69 | |
Jun2022 | ₹2.17 | 3.83 | |
Mar2022 | ₹2.09 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD